NDRA NDRA
Company Profile ↓Company Overview
NDRA (NDRA) is a publicly traded company listed on with a market capitalization of $5.34M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.22.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -10.98% |
| 6 Months: | +23.37% |
| 3 Months: | -6.39% |
| 1 Month: | -8.28% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.72 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 44.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 57.77K | 287.00K | 6.17K | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | 0 | 0 | 6.34K | 168.73K | 6.17K | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.47M | 1.30M | 1.37M | 1.62M | 2.17M |
| Operating Income | -373.46K | -494.31K | -605.11K | -360.70K | -1.06M | -910.93K | -2.84M | -1.82M | -2.36M | -2.75M | -2.33M | -2.64M | -3.10M | -2.89M | -3.26M | -2.58M | -3.20M | -2.65M | -2.86M | -3.57M | -3.42M | -2.94M | -2.99M | -3.13M | -2.78M | -2.23M | -1.51M | - | -1.47M | -1.30M | -1.37M | -1.62M | -2.17M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.42M | -1.27M | -1.33M | -1.58M | -2.13M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.04M | -1.23M | -1.60M | -3.17M | -1.31M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -379.48K | -729.11K | -977.90K | -741.62K | -1.43M | -908.91K | -2.83M | -1.85M | -2.76M | -2.75M | -2.33M | -3.41M | -3.32M | -2.89M | -3.26M | -2.27M | -3.20M | -2.66M | -2.86M | -3.59M | -3.44M | -2.94M | -2.56M | -3.10M | -2.78M | -2.23M | -2.35M | - | -1.04M | -1.23M | -1.60M | -3.17M | -1.31M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.54 | - | -1.86 | -1.71 | -2.10 | - | -1.09 |
| R&D Expense | 198.88K | 103.64K | 137.54K | 95.81K | 174.72K | 300.53K | 1.67M | 839.76K | 1.16M | 1.77M | 1.30M | 1.47M | 1.52M | 1.49M | 1.77M | 1.14M | 1.74M | 1.17M | 1.21M | 1.85M | 1.83M | 1.39M | 1.40M | 1.63M | 1.04M | 716.37K | 794.44K | - | 528.68K | 381.06K | 432.11K | - | 776.41K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 515.58K | 351.62K | 6.17K | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 279.70K | 178.84K | 6.17K | 0 | 0 | 0 | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | 13.16M | 10.52M | 10.82M | 5.76M |
| Operating Income | -1.79M | -4.63M | -9.02M | -10.84M | -11.50M | - | -13.16M | -10.52M | -10.82M | -5.76M |
| EBITDA | - | - | - | - | - | - | -12.92M | -10.25M | -10.61M | -5.61M |
| Interest Expense | - | - | - | - | - | 0 | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | -13.18M | -10.06M | -11.51M | -7.03M |
| Tax Provision | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Net Income | -2.78M | -5.38M | -9.80M | -13.31M | -11.73M | - | -13.18M | -10.06M | -11.51M | -7.03M |
| Diluted EPS | - | - | - | - | - | - | -7,980.00 | -2,766.85 | -56.94 | -8.93 |
| R&D Expense | 495.38K | 1.93M | 4.72M | 6.57M | 5.92M | 5.48M | 6.55M | 5.00M | 3.19M | 1.85M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 490.76K | 6.12M | 7.22M | 7.18M | 8.76M | - | 9.27M | 6.75M | 4.45M | 3.85M |
| Current Assets | - | - | - | - | - | - | 5.38M | 3.03M | 3.43M | 967.97K |
| Cash & Equivalents | - | - | - | - | - | - | 4.89M | 2.83M | 3.23M | 762.37K |
| Inventory | - | - | - | - | - | 1.28M | 2.64M | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | 1.38M | 848.21K | 974.58K | 2.42M | 1.60M | - | 2.07M | 1.10M | 1.89M | 1.59M |
| Current Liabilities | 1.38M | 848.21K | 974.58K | 2.07M | 986.66K | - | 1.70M | 903.10K | 605.23K | 750.96K |
| Long Term Debt | - | - | - | - | - | 28.48K | - | - | - | - |
| Total Debt | - | - | - | - | - | - | 546.63K | 394.40K | 584.42K | 492.35K |
| Total Equity | -893.77K | 5.28M | 6.25M | 4.76M | 7.17M | - | 7.20M | 5.66M | 2.56M | 2.26M |
| Shares Outstanding | - | - | - | - | - | - | 1.81K | 5.94K | 536.91K | 1.18M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.32M | -3.30M | -7.70M | -8.59M | -10.75M | - | -12.77M | -9.55M | -7.40M | -5.18M |
| Investing Cash Flow | 0 | -7.86K | -100.00K | -43.59K | -75.33K | - | -202.58K | -24.72K | -12.80K | -3.02M |
| Financing Cash Flow | 1.44M | 8.77M | 8.67M | 8.34M | 11.88M | - | 8.40M | 7.52M | 7.81M | 5.73M |
| Capital Expenditure | - | -7.86K | -100.00K | -43.59K | -75.33K | - | -202.58K | -33.88K | -16.00K | -3.02M |
| Free Cash Flow | - | -3.31M | -7.80M | -8.63M | -10.82M | - | -12.97M | -9.58M | -7.42M | -8.20M |
| Net Change in Cash | - | - | - | - | - | - | -4.57M | -2.06M | 395.57K | -2.47M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 54.3% | 50.9% | 100.0% | - | - | - | - | - | - | - |
| Operating Margin % | -347.5% | -1,315.6% | -146,080.5% | - | - | - | - | - | - | - |
| Net Margin % | -538.3% | -1,529.2% | -158,669.6% | - | - | - | - | - | - | - |
| ROE % | 310.5% | -101.9% | -156.8% | -279.5% | -163.6% | - | -182.9% | -177.8% | -449.5% | -310.9% |
| ROCE % | 200.5% | -87.7% | -144.3% | -212.5% | -147.9% | - | -173.8% | -179.8% | -281.2% | -185.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NDRA
ASP Isotopes Inc. (NDRA) to host investor meetings at Citi 2026 Natural Resources Conference - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZXk1WFB5QjdEOTBWTjQweVkxbC1ISkFHUFpaemhiT2NvOW1xZlVzNEJDOExWdk01YWU0TnJQMzlOaEhaOFZxMGU4VDNVckVaazlnR0JNXzdqVTQ3dlJOTlVnTzRqaGc1eUVWZTh6VnBXVUV2dFJzMWpGSnlXNDhQZ0wwdVVyZXdFc2JCYm…
NDRA|ENDRA Life Sciences Inc|Price:4.700|Chg%:+0.400 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE0wbExaeTZCRkxfUmxhM2RMTjNxeXZoMktaRzlsRm9Ia0g0WFdUSE1UUmRDNXF5ZHR2Ny1YSVhiZU9vdU03VEVJUG92ai0tSFF2T21RZWdDeXZ6eVNWVVB1eFh1ai1hTl8walhDb1h3?oc=5" target="_blank">NDRA|ENDRA Life Sci…
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOb2NhNUV2WjcwYjJHazRfQUc5cVFYNnUxLTlya05Oc0ZvVUtTRWt1bEl2R2hYeDRaaVlvYlAwQ3UzcmROdnRzSmpnZDlGWDVOa0hEZUt3VS1yZ1RtdnlGT2t1cXZ2d3FkU1hocFYyUXdzR2hEZlhTQnZsaHByTUlBbzhYbUFLZWlYREJfc1…
NDRA Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9wQWQtVnJkbVREbmNTYV90WkhHdXhFZi1HekNEQms2S2VBaDdTMGwxS3djV1B3YTB2XzlOWU0wWU5BZlNKallqRzBQeUM5M2ExekQzNUZHbnZpbW9FQXRlZDd4UWhjWmVHa3FkdzBpMFV0YTdoQ2RyMDB3?oc=5" target="_blank">NDR…
ASP Isotopes' Noble Africa unit to merge with ENDRA Life Sciences unit in $50M deal (ASPI:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbW5wTWpsOFNYU0IzdWNoVzFlVlhteThBcHRkb0FLVjBBZ1J3elQ1eF9NSGZaeExweW1iZFlobG10dGJ6emw2MVRiTVoyQXFKLTBOcG9BVDlwTDNBSTdtM2NSZ1hFWFY4V3p6cjFFXzAxQ0ZGaEcwN3J4eXJwd0hhZ19tMHB3aHJ4WEhpSD…
ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Deal - Stocktwits
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPNUZhbmFZX3dGVVNBZnZSWEhoTlFRNFgtRlBTeFdkRlFOUWhrdmVTU1JzQktxWk9tQUV5YkpKMExDOFVDUUYxVmxMbmlEZEhzdW9BdF9uN01nR2ZrVnhXNWdBajVSaXVyVUF2OHBqblZzNnNiMkJTRlVnamgyeUJLZlFHT2xsb2R5VzNja2…
NDRA — Frequently Asked Questions
What is the current share price of NDRA?
As of 2026-08-05 17:25 PDT, NDRA trades at $4.54 on NASDAQ/NYSE. Its 52-week range is $3.26 to $8.12.
What is the market capitalisation of NDRA?
NDRA has a market capitalisation of $5.34M on NASDAQ/NYSE.
What is the P/E ratio of NDRA?
NDRA trades at a trailing price-to-earnings (P/E) ratio of -0.51. Its price-to-book (P/B) ratio is 2.36.
Is NDRA a good stock to buy?
This page provides a data-driven analysis of NDRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.